Artificial intelligence (AI) is a disruptive technology that involves the use of computerised algorithms to dissect complicated data. Among the most promising clinical applications of AI is diagnostic imaging, and mounting attention is being directed...
Cardiovascular disease (CVD) is one of the most serious health disorders with increasing prevalence and high morbidity and mortality. Although diagnosis and treatment of CVD have achieved huge breakthrough in recent years, it still needs additional e...
Medical archives (Sarajevo, Bosnia and Herzegovina)
Feb 1, 2020
INTRODUCTION: The World Health Organization has estimated that 12 million deaths occur worldwide, every year due to Heart diseases. Half the deaths in the developed countries are due to cardiovascular diseases. The early prognosis of cardiovascular d...
Methodist DeBakey cardiovascular journal
Jan 1, 2020
Cardiovascular disease is the leading cause of mortality in Western countries and leads to a spectrum of complications that can complicate patient management. The emergence of artificial intelligence (AI) has garnered significant interest in many ind...
Methodist DeBakey cardiovascular journal
Jan 1, 2020
The number of cardiovascular imaging studies is growing exponentially, and so is the need to improve clinical workflow efficiency and avoid missed diagnoses. With the availability and use of large datasets, artificial intelligence (AI) has the potent...
The computer science technology trend called artificial intelligence (AI) is not new. Both machine learning and deep learning AI applications have recently begun to impact cardiovascular medicine. Scientists working in the AI domain have long recogni...
Artificial intelligence (AI) holds promise for cardiovascular medicine but is limited by a lack of large, heterogeneous and granular data sets. Blockchain provides secure interoperability between siloed stakeholders and centralized data sources. We d...
OBJECTIVE: This study evaluated the characteristics of new users of sodium glucose co-transporter 2 inhibitors (SGLT2i) in clinical practice to assess the applicability of the findings from clinical trials (Empagliflozin, Cardiovascular Outcomes and ...
Revista da Associacao Medica Brasileira (1992)
Dec 1, 2019
Artificial intelligence (AI) is a field of computer science that aims to mimic human thought processes. AI techniques have been applied in cardiovascular medicine to explore novel genotypes and phenotypes in existing diseases, improve the quality of ...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.